EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Staphyloma-induced Serous Maculopathy

Monica Ravenstijn, José P Martinez Ciriano, Gerard W de Graaf, Caroline C W Klaver, Suzanne Yzer

Ophthalmology Retina · 2024

DOI: 10.1016/j.oret.2023.11.008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ophthalmology Retina, 2024. Verfasst von Monica Ravenstijn und 4 weiteren Autor:innen. Beteiligte Einrichtung: Rotterdam Ophthalmic Institute, Rotterdam Eye Hospital, Rotterdam, the Netherlands; Department of Ophthalmology, Erasmus University Medical Center, R…. Hauptthemen laut MEDLINE: Visual Acuity, Tomography, Optical Coherence, Fluorescein Angiography. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Horizon 2020, Landelijke Stichting voor Blinden en Slechtzienden, Rotterdamse Stichting Blindenbelangen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To study the natural course of staphyloma-induced serous maculopathy (SISM) and the effects of treatments. DESIGN: Retrospective case series. PARTICIPANTS: This retrospective analysis included 26 eyes of 20 patients with SISM and at least 12 months of follow-up. METHODS: Medical records were reviewed for patient demographics, such as age, sex, spherical equivalent, best-corrected visual acuity (BCVA), type of staphyloma, and imaging characteristics. Spectralis OCT B-scans were evaluated for the presence and height of the serous retinal detachment (SRD) at each follow-up visit. An SRD episode was defined as a period with SRD in 1 patient. MAIN OUTCOME MEASURES: Changes in SRD height and BCVA. RESULTS: Twenty-six eyes of 20 patients (70% female) were included. The mean age was 54 ± 11 years, and the mean spherical equivalent was -4.8 ± 3.3 diopters at baseline. The staphyloma was located inferior in 12 eyes (46%), inferonasal in 7 eyes (27%), and nasal in 7 eyes (27%). The mean follow-up duration was 73 ± 34 months. During follow-up, the SRD height fluctuated in all eyes, with a mean change of 125 ± 56 μm. The SRD disappeared completely during follow-up in 13 eyes (50%) and then reappeared in 7 eyes (35%). Resolution occurred spontaneous in 8 eyes (31%). The median time of an SRD episode was 25 (interquartile range 14-57) months. Treatment was performed in 20 eyes (77%) and led to resolution of SRD in 3 of the 15 photodynamic therapy treatments (21%), 2 of 5 (40%) anti-VEGF series, and 2 of 4 eyes (50%) treated with topical prednisolone. Best-corrected visual acuity at the final visit (0.42 ± 0.25) was not significantly different from BCVA at baseline (0.34 ± 0.27 logarithm of the minimum angle of resolution, P = 0.07), nor was BCVA change significantly different between treated eyes (n = 19) and nontreated eyes (n = 7, P = 0.3). CONCLUSION: Serous retinal detachment in patients with SISM fluctuated over time and resolved without treatment in 31% of the eyes. Because treatment does not change the course of BCVA, a wait-and-see policy is advocated in these patients on the exclusion of treatable causes of SRD. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Visual AcuityTomography, Optical CoherenceFluorescein AngiographyHumansFemaleMaleRetrospective StudiesMiddle AgedFollow-Up StudiesAdultAgedCentral Serous ChorioretinopathyAngiogenesis InhibitorsFundus OculiRetinal DetachmentPhotochemotherapyIntravitreal InjectionsGlucocorticoidsVascular Endothelial Growth Factor A

Stichwörter der Autor:innen

MyopiaNatural coursePosterior staphylomaTreatment

Substanzen

Angiogenesis InhibitorsGlucocorticoidsVascular Endothelial Growth Factor A

Autor:innen und Institutionen

  • Rotterdam Ophthalmic Institute, Rotterdam Eye Hospital, Rotterdam, the Netherlands; Department of Ophthalmology, Erasmus University Medical Center, Rotterdam, the Netherlands. Electronic address: monicaravenstijn@gmail.…
  • Department of Ophthalmology, Rotterdam Eye Hospital, Rotterdam, the Netherlands.
  • Department of Ophthalmology, Erasmus University Medical Center, Rotterdam, the Netherlands; Department of Epidemiology, Erasmus University Medical Center, Rotterdam, the Netherlands; Department of Ophthalmology, Radboud…
  • Department of Ophthalmology, Radboudumc, Nijmegen, the Netherlands.

Förderung

  • Horizon 2020
  • Landelijke Stichting voor Blinden en Slechtzienden
  • Rotterdamse Stichting Blindenbelangen
  • Stichting Wetenschappelijk Onderzoek Oogziekenhuis
  • European Research Council
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek
  • Horizon 2020 Framework Programme
  • Oogfonds

Zitieren

APA

Ravenstijn, M., Martinez Ciriano, J. P., de Graaf, G. W., Klaver, C. C. W., & Yzer, S. (2024). Staphyloma-induced Serous Maculopathy. Ophthalmology Retina. https://doi.org/10.1016/j.oret.2023.11.008

Vancouver

Ravenstijn M, Martinez Ciriano JP, de Graaf GW, Klaver CCW, Yzer S. Staphyloma-induced Serous Maculopathy. Ophthalmology Retina. 2024. doi:10.1016/j.oret.2023.11.008

BibTeX
@article{Ravenstijn2024,
  author = {Ravenstijn, Monica and Martinez Ciriano, José P and de Graaf, Gerard W and Klaver, Caroline C W and Yzer, Suzanne},
  title = {Staphyloma-induced Serous Maculopathy},
  journal = {Ophthalmology Retina},
  year = {2024},
  doi = {10.1016/j.oret.2023.11.008}
}
Kostenlos starten →